Harvey Brandwein

1.6k total citations
39 papers, 1.3k citations indexed

About

Harvey Brandwein is a scholar working on Molecular Biology, Endocrinology and Physiology. According to data from OpenAlex, Harvey Brandwein has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Endocrinology and 7 papers in Physiology. Recurrent topics in Harvey Brandwein's work include Immunotherapy and Immune Responses (5 papers), Escherichia coli research studies (4 papers) and Bacteriophages and microbial interactions (4 papers). Harvey Brandwein is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Escherichia coli research studies (4 papers) and Bacteriophages and microbial interactions (4 papers). Harvey Brandwein collaborates with scholars based in United States, France and Italy. Harvey Brandwein's co-authors include Ferid Murad, John Lewicki, Marjorie A. Ariano, Jon A. Rowley, Andrew Campbell, John W. Hadden, Eytan Abraham, Steve Oh, Ralph A. Giannella and Sunny Dzik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Harvey Brandwein

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harvey Brandwein United States 20 492 245 218 203 156 39 1.3k
F X Maquart France 17 390 0.8× 147 0.6× 171 0.8× 141 0.7× 61 0.4× 33 1.5k
J. Labat‐Robert France 26 529 1.1× 210 0.9× 126 0.6× 150 0.7× 72 0.5× 107 1.8k
Chantal Legrand France 25 806 1.6× 70 0.3× 214 1.0× 186 0.9× 65 0.4× 73 1.7k
Robert J. Wilkins United Kingdom 25 610 1.2× 266 1.1× 60 0.3× 146 0.7× 134 0.9× 79 1.8k
Sung‐Ho Kook South Korea 26 980 2.0× 135 0.6× 155 0.7× 165 0.8× 186 1.2× 75 1.8k
Kamil Can Akçalı Türkiye 23 912 1.9× 169 0.7× 243 1.1× 255 1.3× 128 0.8× 61 2.1k
Laxmansa C. Katwa United States 29 824 1.7× 365 1.5× 112 0.5× 228 1.1× 91 0.6× 67 2.4k
Sun Young Lee South Korea 28 1.2k 2.5× 159 0.6× 139 0.6× 111 0.5× 141 0.9× 71 2.2k
M Adolphe France 23 531 1.1× 134 0.5× 146 0.7× 117 0.6× 140 0.9× 109 1.7k
Kwang Il Nam South Korea 25 1.1k 2.2× 81 0.3× 146 0.7× 274 1.3× 91 0.6× 59 2.0k

Countries citing papers authored by Harvey Brandwein

Since Specialization
Citations

This map shows the geographic impact of Harvey Brandwein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harvey Brandwein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harvey Brandwein more than expected).

Fields of papers citing papers by Harvey Brandwein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harvey Brandwein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harvey Brandwein. The network helps show where Harvey Brandwein may publish in the future.

Co-authorship network of co-authors of Harvey Brandwein

This figure shows the co-authorship network connecting the top 25 collaborators of Harvey Brandwein. A scholar is included among the top collaborators of Harvey Brandwein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harvey Brandwein. Harvey Brandwein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clarke, Dominic, et al.. (2020). Transitioning from development to commercial: risk-based guidance for critical materials management in cell therapies. Cytotherapy. 22(11). 669–676. 4 indexed citations
2.
Campbell, Andrew M., Jon A. Rowley, Knut Niß, et al.. (2015). Concise Review: Process Development Considerations for Cell Therapy. Stem Cells Translational Medicine. 4(10). 1155–1163. 101 indexed citations
3.
Wolf, Gregory T., Willard E. Fee, Robert W. Dolan, et al.. (2011). Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer. Head & Neck. 33(12). 1666–1674. 44 indexed citations
4.
Berinstein, Neil L., Gregory T. Wolf, Paul H. Naylor, et al.. (2011). Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen. Cancer Immunology Immunotherapy. 61(6). 771–782. 35 indexed citations
5.
Freeman, Sara M., José Luis Franco, Daniel E. Kenady, et al.. (2010). A Phase 1 Safety Study of an IRX-2 Regimen in Patients With Squamous Cell Carcinoma of the Head and Neck. American Journal of Clinical Oncology. 34(2). 173–178. 25 indexed citations
6.
Czystowska, Malgorzata, Mirosław J. Szczepański, Marta Szajnik, et al.. (2010). Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic. Cancer Immunology Immunotherapy. 60(4). 495–506. 19 indexed citations
7.
Czystowska, Malgorzata, Jinhua Han, Mirosław J. Szczepański, et al.. (2009). IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death. Cell Death and Differentiation. 16(5). 708–718. 63 indexed citations
8.
Egan, James E., et al.. (2007). IRX-2, a Novel In Vivo Immunotherapeutic, Induces Maturation and Activation of Human Dendritic Cells In Vitro. Journal of Immunotherapy. 30(6). 624–633. 31 indexed citations
9.
Moroff, Gary, Samuel Sowemimo‐Coker, Stephen J. Finch, et al.. (2005). The Influence of Various Hematology Analyzers on Component Platelet Counts. Transfusion Medicine Reviews. 19(2). 155–166. 10 indexed citations
10.
Lewis, Michael A. O., et al.. (2002). Method for qualifying microbial removal performance of 0.1 micron rated filters. Part III: bacterial challenge tests on 0.2/0.22 and 0.1 micron rated filter cartridges with Hydrogenophaga (formerly Pseudomonas) pseudoflava.. PubMed. 55(6). 393–416. 5 indexed citations
11.
Howard, G. A., et al.. (2002). Method for qualifying microbial removal performance of 0.1 micron rated filters. Part I: characterization of water isolates for potential use as standard challenge organisms to qualify 0.1 micron rated filters.. PubMed. 55(6). 346–72. 6 indexed citations
12.
Howard, G. A., et al.. (2001). Retention of water-borne bacteria by membrane filters. Part II: Scanning electron microscopy (SEM) and fatty acid methyl ester (FAME) characterization of bacterial species recovered downstream of 0.2/0.22 micron rated filters.. PubMed. 55(2). 87–113. 6 indexed citations
13.
Brandwein, Harvey, et al.. (2000). Membrane filtration for virus removal.. PubMed. 102. 157–63. 5 indexed citations
14.
Finch, S., et al.. (1999). Process control procedures to augment quality control of leukocyte-reduced red cell blood products. Statistics in Medicine. 18(10). 1279–1289. 5 indexed citations
15.
Sowemimo‐Coker, Samuel, et al.. (1998). White cell subsets in apheresis and filtered platelet concentrates. Transfusion. 38(7). 650–657. 40 indexed citations
16.
Brandwein, Harvey, et al.. (1997). Removal of Mycobacterium Species by Breathing Circuit Filters. Infection Control and Hospital Epidemiology. 18(4). 252–254. 3 indexed citations
17.
Brandwein, Harvey, et al.. (1997). Removal of Mycobacterium Species by Breathing Circuit Filters. Infection Control and Hospital Epidemiology. 18(4). 252–254. 9 indexed citations
18.
Prati, Daniele, Harvey Brandwein, Sunny Dzik, et al.. (1996). Multicenter Evaluation of the 3% Paraformaldehyde Method for White Cell Counting in Leukocyte‐Reduced Red Blood Cells. Vox Sanguinis. 70(4). 241–245. 16 indexed citations
19.
20.
Brandwein, Harvey, John Lewicki, Scott A. Waldman, & Ferid Murad. (1982). Effect of GTP analogues on purified soluble guanylate cyclase.. Journal of Biological Chemistry. 257(3). 1309–1311. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F X Maquart Breakdown of academic impact, for papers by J. Labat‐Robert Breakdown of academic impact, for papers by Chantal Legrand Breakdown of academic impact, for papers by Robert J. Wilkins Breakdown of academic impact, for papers by Sung‐Ho Kook Breakdown of academic impact, for papers by Kamil Can Akçalı Breakdown of academic impact, for papers by Laxmansa C. Katwa Breakdown of academic impact, for papers by Sun Young Lee Breakdown of academic impact, for papers by M Adolphe Breakdown of academic impact, for papers by Kwang Il Nam
Rankless by CCL
2026